The canonical conformational states occupied by most ligand-gated ion channels, and many cell-surface receptors, are the resting, activated, and desensitized states. While the resting and activated states of multiple receptors are well characterized, elaboration of the structural properties of the desensitized state, a state that is by definition inactive, has proven difficult. Here we use electrical, chemical, and crystallographic experiments on the AMPAsensitive GluR2 receptor, defining the conformational rearrangements of the agonist binding cores that occur upon desensitization of this ligand-gated ion channel. These studies demonstrate that desensitization involves the rupture of an extensive interface between domain 1 of 2-fold related glutamate-binding core subunits, compensating for the ca. 21 of domain closure induced by glutamate binding. The rupture of the domain 1 interface allows the ion channel to close and thereby provides a simple explanation to the long-standing question of how agonist binding is decoupled from ion channel gating upon receptor desensitization.
INTRODUCTION
Chemical communication across cell membranes is commonly mediated by ligand-gated ion channels and cellsurface receptors. In many instances, diffusible ligands (agonists) bind to the extracellular domain of the receptor, induce specific conformational changes, and stabilize the activated state. Once activated, the agonist either unbinds from the receptor and the receptor returns to the apo, resting state (deactivation), or the agonist bound receptor undergoes one or more additional conformational changes that decouple the action of agonist binding from receptor activation, i.e., the receptor is desensitized by or insensitive to the activating action of agonist. While there are a number of receptors for which we have atomic-scale views of resting and activated states (Armstrong et al., 2003; Furukawa and Gouaux, 2003; Miyazawa et al., 2003) , we know little about the conformational changes that occur upon receptor desensitization and the resulting structure of the desensitized state.
Ionotropic glutamate receptors (iGluRs) are ligandgated ion channels activated by the binding of the neurotransmitter glutamate. Activation triggers the opening of cation-permeable channels, thereby transducing a chemical signal derived from the presynaptic release of glutamate to an electrical signal that results in depolarization of the postsynaptic cell (for recent reviews, see Dingledine et al., 1999; Madden, 2002; Mayer, 2006; Mayer and Armstrong, 2004; Oswald, 2004) . The portion of the iGluRs involved in glutamate binding includes two discontinuous polypeptide segments, called S1 and S2 (Stern-Bach et al., 1994) , that, when linked together, fold to a two-domain or ''clamshell''-like structure: the S1S2 ligand-binding core (Armstrong et al., 1998; Kuusinen et al., 1995) ( Figure S1 ). Structural studies on GluR2 S1S2 have shown that the ligand-binding domains assemble as a pair of dimers in the full-length, tetrameric receptor (Armstrong and Gouaux, 2000; Sun et al., 2002) .
Activation of the GluR2 receptor involves binding of glutamate to the agonist-binding domain clamshell, followed by closure of the clamshell by approximately 21 (Armstrong and Gouaux, 2000) . Because the ligand-binding domains are braced against each other in a back-toback fashion, this simple domain closure is transduced to the ion channel domain, leading to opening of the conductive pore (Sun et al., 2002) . Deactivation is simply the reverse of this process, i.e., reopening of the clamshell, closure of the conductive pathway, and release of glutamate. Current understanding of the molecular mechanism of desensitization, by contrast, is limited to observations that disruption of the nondesensitized dimer interface, as exemplified by many GluR2 S1S2 structures (Sun et al., 2002) , modulates the rate and extent of receptor desensitization. We are motivated to map the conformational changes that occur upon desensitization to understand how agonist binding is decoupled from ion channel activation, not only because the GluR2 receptor undergoes desensitization on a millisecond timescale, exhibiting less than a few percent of the ''peak'' or nondesensitized current at steady state (see for example Horning and Mayer, 2004; Koike et al., 2000; Krampfl et al., 2002) but also because this rapid decrease in ion channel activity may play an important role in modulating synaptic currents.
Traditional methods for stabilizing receptors in specific conformational states include the judicious application of mutations or the use of small-molecule agonists, antagonists, or allosteric modulators. Indeed, such techniques were crucial in establishing that the domain 1-domain 1 dimer interface in the GluR2 S1S2 crystal structures represented the nondesensitized state of the receptor (Sun et al., 2002) . By contrast, tools such as sodium thiocyanate, which stabilize the desensitized state of AMPA receptors (Bowie and Smart, 1993; Donevan and Rogawski, 1998) , or mutations such as Ser754 to Asp, which destabilize the nondesensitized state (Partin et al., 1996; Sun et al., 2002) , have proven ineffective in stabilizing the desensitized state to a sufficient extent to allow for detailed biophysical and crystallographic characterization. Here we apply disparate experimental approaches, including chemical modification, electrophysiology, and crystallography, to independently probe the conformational rearrangements of the extracellular glutamate-binding core subunits that accompany receptor desensitization.
RESULTS

Protein Constructs
To minimize undesired, nonspecific reactions between thiol-directed chemical-modifying reagents and endogenous cysteine residues, we modified the full-length rat GluR2 (flip) (Sommer et al., 1990) . We first deleted the entire amino-terminal domain (ATD). Justification for this deletion comes from studies showing that GluR2 receptors in which the ATD has been genetically removed retain ligand-binding affinities, agonist potencies, and kinetic properties similar to the wild-type receptor (Horning and Mayer, 2004; Pasternack et al., 2002) . Second, we mutated native, free cysteine residues in the S1S2 ligandbinding core (C425A, C436V) and the transmembrane domains of this ATD-deleted construct to either isosteric amino acids or to noncysteine amino acids present at equivalent positions in related glutamate receptors (C528Y, C589S). Of the remaining cysteine residues, two form a disulfide bond within S1S2 (C718/C773) and the third (C815) is intracellular. We refer to the ATD-deleted receptor with the three native cysteines as the GluR2 DATD construct, a construct that has a glutamate dose-response curve, measured by two-electrode voltage-clamp (TEVC), similar to the wild-type receptor ( Figure S1 ). The GluR2 S1S2 ligand-binding core constructs contain all native cysteine residues.
Dimer Interface Becomes More Accessible upon Desensitization
The nondesensitized state of the GluR2 receptor is stabilized by extensive contacts between interdigitated residues at the 2-fold related domain 1-domain 1 interface of the S1S2 ligand-binding core (Horning and Mayer, 2004; Sun et al., 2002) . Many of these residues are largely inaccessible to bulk solvent, as judged by atomic structures (Sun et al., 2002) . One such residue is Glu 486, which makes a critical salt link to Lys493 in the 2-fold related subunit (Armstrong and Gouaux, 2000; Horning and Mayer, 2004; Sun et al., 2002) (Figure 1A ). To probe whether sites within the dimer interface become more accessible upon desensitization, we examined the rate of modification of the Glu486 to Cys mutant (E486C) using sodium (2-sulfonatoethyl)methane thiosulfonate (MTSES) (Akabas et al., 1992 (Akabas et al., , 1994 . Derivatization of E486C with MTSES generates an anionic side chain that is larger than glutamate. Because previous studies have shown that even conservative mutation of residues located within the dimer interface generally increases the extent of receptor desensitization (Horning and Mayer, 2004; Sun et al., 2002) , we hypothesized that modification of E486C with MTSES would also increase the extent of receptor desensitization, thereby decreasing the magnitude of ''steady-state'' or ''plateau'' current, as measured by TEVC in the presence of saturating concentrations of glutamate.
To probe the cysteine accessibility of E486C under conditions that populate either the nondesensitized or desensitized states of the GluR2 receptor, we measured apparent reaction rates with MTSES under three different conditions: (1) 10 mM 6,7-dinitro-2,3-quinoxalinedione (DNQX), a competitive antagonist that will stabilize the closed-channel, nondesensitized state (Honoré et al., 1988) ; (2) 1 mM glutamate, a full agonist that will populate the closed-channel, desensitized state; and (3) 1 mM glutamate and 100 mM cyclothiazide (CTZ) (Partin et al., 1993; Yamada and Tang, 1993) , a combination of agonist and modulator that will stabilize the open channel, nondesensitized state ( Figures 1B-1D) .
We found that MTSES modification of E486C is slow in the presence of either DNQX or glutamate and CTZ, with second-order rate constants of 101 and 15.9 M À1 s À1 , respectively ( Figure 1E ). We suggest that the slow rate of reaction of MTSES in the presence of cyclothiazide is due to the fact that cyclothiazide stabilizes the dimer interface in a compact conformation, rendering E486C relatively inaccessible to modification. It is possible that CTZ inhibited the MTSES reaction via direct steric effects because modeling the E486C cysteine into the GluR2/CTZ cocrystal structure shows that the cysteine sulfhydryl is $6 Å from CTZ (Sun et al., 2002) . In contrast to the slow MTSES reaction rates measured under the glutamate/CTZ and DNQX conditions, the MTSES reaction rate in the presence of glutamate was 3312 M À1 s À1 , $33 times faster than in the presence of DNQX ( Figure 1E ). The fact that the rate of MTSES modification of E486C is at least $33-fold faster under conditions that populate the desensitized state than it is under conditions that populate the nondesensitized state supports two important conclusions. First, the slower reaction rate in the absence of glutamate suggests that the dimer interface is compact or occluded in the resting state, a conclusion that has, until now, been speculative. Second, the faster reaction rate of E486C under conditions that favor the desensitized state suggests that the thiol moiety is more accessible in the desensitized state. Therefore, we suggest that the domain 1-domain 1 dimer interface ''opens up'' and is more accessible upon transition from the non desensitized state to the desensitized state.
Indeed, similar MTSES experiments on K493C, a residue that forms a salt bridge with E486 across the dimer interface in the nondesensitized conformation, yield rates of reaction of 10, 34.9, and 3016 M À1 s À1 in the closed-channel, nondesensitized state (+DNQX), the open-channel, nondesensitized state (+glutamate/CTZ), and the closedchannel, desensitized state (+glutamate), respectively, thereby reinforcing the conclusion that residues in the domain 1-domain 1 dimer interface become more accessible upon receptor desensitization.
Measurements of Domain-Domain Separation
To measure the separation distance between residues in the dimer interface upon desensitization, we carried out a series of chemical modification experiments using thiol-directed bifunctional crosslinkers of four different lengths, together with three single cysteine mutants of the GluR2 DATD construct (Figures 2A and 2B) . We hypothesized that the shorter crosslinkers will block desensitization because they will restrain the domain 1-domain 1 interface to a nondesensitized or nondesensitized-like conformation, while the longer crosslinkers will have no effect on the extent of receptor desensitization because they will not be ''pulled'' to their fully extended conformation upon receptor desensitization. In other words, the shorter crosslinkers will potentiate glutamate-induced equilibrium currents, while the crosslinkers that are long enough to span the desensitized conformation will not potentiate equilibrium currents. Near the ''top'' of the dimer interface is G739C, and all four crosslinkers potentiated glutamate-induced currents ( Figure 2C ). In the case of G743C, the three shortest crosslinkers potentiated equilibrium currents. However, following reaction with the longest crosslinker, the glutamate-induced equilibrium currents were actually smaller than the currents observed prior to modification. At K493C, the two shortest crosslinkers potentiated equilibrium currents, but the third shortest (18 Å ) did not potentiate currents ( Figure 2C ; Table S1 ). The extent of crosslinker-induced potentiation for the three cysteine mutants ranged from 7-to 33-fold with K493C exhibiting the greatest effect from crosslinking and G743C exhibiting the least ( Figure 2D ).
The crosslinking data, together with the crystal structure of the nondesensitized state, allow us to estimate the distance that residues 739, 743, and 493 move upon desensitization. Using the GluR2 S1S2-L483Y dimer as a model for the nondesensitized state (Sun et al., 2002) , we modeled cysteines into positions 739, 743, and 493, choosing side chain rotomer conformations that minimized the sulfur to sulfur distances. Subtraction of the extended length of the longest potentiating crosslinker from the distance between the 2-fold related cysteine sulfur atoms yields a lower bound for the distance change accompanying desensitization (Table S1 ). Specifically, residues 739, 743, and 493 move more than 13.9, 9.1, and 6.9 Å apart, respectively, upon desensitization. Using the lengths of the shortest nonpotentiating crosslinkers we estimate that the distance change upon desensitization for residues 743 and 493 is less than 16.2 and 12.4 Å , respectively. These calculations reveal a pattern in which the largest movements occur at the ''top'' of the dimer interface and the smallest movements take place near the ''bottom.'' How do we know that the bifunctional crosslinkers have reacted with the desired cysteine residues and are thus faithfully measuring the conformational changes that occur upon desensitization? Using chemical and electrophysiological methods we certainly cannot prove that the crosslinkers are faithful reporters. Thus, to probe the conformational changes occurring upon desensitization using completely different approaches, we examined additional single cysteine mutants using electrophysiological and crystallographic methods.
Stabilization of the Desensitized State
In the course of analyzing the gating properties of cysteine mutants within or adjacent to the dimer interface by TEVC, we encountered a mutant, S729C, that exhibited unusually small currents (24 nA ± 12 nA; n = 20). Neither increasing the dose of injected cRNA nor increasing the duration of oocyte incubation between cRNA injection and TEVC recording significantly increased the currents elicited by glutamate application. Surprisingly, the current magnitude was increased $56-fold, to 1-2 mA, following a 5 min exposure to 2 mM dithiothreitol (DTT) (Figure 3A ), while the same DTT application had no effect on the parent GluR2 DATD construct. Analysis of oocytes injected with S729C cRNA by SDS-PAGE and western blotting demonstrated that under nonreducing conditions the majority of the protein migrated at a position that was consistent with (B) Whole-cell western blots of uninjected oocytes (un) and oocytes injected with RNA encoding the parent DATD, K493C, S729C/L483Y, and S729C constructs, run under nonreducing and reducing (+100 mM b-mercaptoethanol) conditions. The equivalent of 1/2 an oocyte was loaded per lane. Whereas the S729C runs as mostly dimer under nonreducing conditions, the relative proportion of dimer is decreased in the context of the L483Y substitution. (C) Plot of fold change in current following 5 min exposure to 2 mM DTT. Of the nine single-cysteine mutants tested, three (I664C, G725C, and S729C) had larger currents after reduction. The current change measured for the remaining cysteine mutants following DTT treatment was similar to that of control oocytes (DATD) (10%-30% attenuation) and was indistinguishable from rundown (n R 4 for all constructs). Note the different scale for S729C. (D) Mapping of DTT sensitivity to the S1S2 surface. Blue patches are DTT-insensitive positions, orange patches are mildly DTT-sensitive sites, and the red patch is S729C. Residues in panels (C) and (D) are color-coded similarly. All errors are SEM. a dimer of GluR2 DATD subunits. By contrast, both GluR2 DATD and GluR2 DATD K493C ran as monomers under nonreducing conditions ( Figure 3B ). These electrophysiological and biochemical results support the conclusion that S729C receptors spontaneously form a disulfide bond and that the non-native disulfide bond greatly reduces glutamate-induced equilibrium currents.
Spontaneous disulfide bond formation by S729C was a particularly remarkable result given that in the L483Y crystal structure the hydroxyl groups of Ser729 are located >12 Å apart, much too large a distance to yield the efficiency of disulfide bonding observed in our experiment. For comparison, the distance between cysteines modeled into position K493C was much less, only $5.6 Å , but we observed no spontaneous disulfide bond formation with this mutant ( Figure 3B ). These observations led us to hypothesize that under ambient oxidizing conditions, subunits of the GluR2 DATD S729C receptor were held together by a disulfide bond in an interface not observed in previous crystal structures.
To probe the specificity of spontaneous disulfide bond formation between adjacent subunits by way of DTT sensitivity, we examined eight additional cysteine mutants. Seven of the mutation sites were located on the S1S2 surface within $20 Å of S729. The eighth site was located in loop 2. Mutants were tested for DTT sensitivity by measuring currents before and after a 5 min exposure to 2 mM DTT ( Figure 3C ). Six of the mutants exhibited no significant change in glutamate-induced equilibrium currents following DTT exposure. For two mutants, I664C and G725C, DTT application resulted in potentiation of 3.6-and 2.8-fold, respectively. Mapping the effects of DTT modulation to the S1S2 surface showed that the DTT-sensitive phenotype is localized to a domain 2 face that contains the beginning of the second interdomain b strand (G725 and S729) and the loop connecting helices F and G (I664) ( Figure 3D ).
How does the S729C mutation diminish glutamate-induced ion channel activity? Does the mutant stabilize a resting (inactive) state or a desensitized-like state? If S729C receptors were trapped in the resting state or if disulfide bonding compromised the conformational change leading to receptor activation (i.e., domain closure), then we would expect the receptors to have an increased agonist dissociation constant (K D ) or agonist potency (EC 50 ) for ligands such as glutamate or AMPA. To directly determine K D values, we carried out 3 H-AMPA binding assays. Binding measurements were performed under nonreducing conditions on membranes prepared from HEK293 cells expressing the parent DATD and S729C constructs in which green fluorescent protein (GFP) was fused to receptors' C termini. Fluorescence measurements and western blots showed that the mutant protein was expressed at substantially lower levels than the DATD control and thus accounted for the smaller B max value for S729C relative to DATD ( Figure S2 ). Nonetheless, we found that S729C retained high-affinity 3 H-AMPA binding; the K D values for S729C and DATD were 27.2 nM and 36.2 nM, respectively ( Figure S2) . These values are representative of agonist binding to the desensitized state, as shown previously from measurements carried out in the absence or presence of CTZ (Hall et al., 1993; Kessler et al., 1996) . To verify that the 3 H-AMPA K D measured for nonreduced S729C did not simply reflect binding to a subpopulation of nondisulfide bonded receptors, we measured total 3 H-AMPA binding counts for DATD and S729C in the absence and presence of 2 mM DTT. This concentration of DTT is sufficient to reduce the disulfide bond for >99% of S729C receptors (data not shown). Inclusion of 2 mM DTT in the binding buffer did not change the total counts measured for S729C, indicating that disulfide bonding does not prevent high-affinity AMPA binding ( Figure S2 ). Evaluation of whether the S729C mutation altered glutamate potency (EC 50 ) in a TEVC experiment was complicated by the fact that the glutamate-induced currents prior to reduction were small (i.e., 20 nA) and that following reduction the currents were subject to rapid rundown. Thus it was not possible to accurately determine a glutamate dose-response curve. To circumvent these problems we made the S729H mutant, with the hope of generating a variant of S729C in which the currents were larger and where the addition of Zn +2 would mimic the S729C disulfide bond. Unfortunately, S729H was insensitive to zinc, perhaps because the histidine residues were improperly oriented for zinc binding. However, introduction of a histidine at G725, a site where a cysteine resulted in substantial DTT potentiation (Figure 3) , yielded a mutant where glutamate-induced currents were inhibited by zinc to a substantially greater extent than the parent DATD construct (data not shown).
To determine the effect of zinc on agonist-induced activation of the receptor, we employed the glutamate analog, quisqualate (Jin et al., 2002) (Figures 4A and 4B ). Because the apparent affinity (EC 50 ) for quisqualate is ca. 20-fold higher than that of glutamate, we were able to work at agonist concentrations that did not result in significant sequestration of zinc. With this reversible system we measured the agonist potency for G725H in the presence and absence of zinc. The quisqualate EC 50 values for G725H were 1.3 and 1.9 mM in the absence and presence of 100 mM zinc, respectively ( Figure 4C ). These dose-response data indicate that tethering domain 2 across dimers does not disrupt the activation process, suggesting that zinc inhibits G725H via a noncompetitive mechanism, perhaps by stabilization of a desensitized-like conformation. By analogy, we hypothesize that, under oxidizing conditions, S729C and G725C also stabilize a desensitized-like state.
If the S729C mutant is trapped in a desensitized or desensitized-like state, then incorporation of an additional mutation that stabilizes the nondesensitized state should disfavor formation of the intersubunit S729C disulfide bond, and this effect should reflect itself in electrophysiology and western blot assays. We chose the L483Y mutation because it profoundly stabilizes the nondesensitized state (Stern-Bach et al., 1998). Indeed, we found that oocytes expressing GluR2 DATD L483Y/S729C receptors had large glutamate-induced currents. The increased current size was not entirely due to an alleviation of desensitization by the L483Y mutation because currents from unreduced S729C recorded in the presence of 100 mM CTZ remained small, i.e., in the context of the S729C mutation the extent of CTZ potentiation was much smaller (>10-fold) than that for the wild-type receptor ( Figure 5A ). The degree of DTT potentiation was significantly reduced in L483Y/S729C receptors; the double mutant exhibited only $20-fold current potentiation following DTT reduction ( Figure 5B ). Most importantly, in western blot analysis, the intensity of the L483Y/S729C dimer band was substantially decreased relative to S729C, and there was a concomitant increase in monomer band intensity ( Figure 3B ). These results support the conclusion that a disulfide bond in S729C receptors traps a dimer conformation distinct from that which is stabilized by the L483Y mutation, and the conformation stabilized by S729C may be similar to a desensitized state.
The S1S2 S729C Crystal Structure Depicts a ''Relaxed'' Dimer Conformation The presence of the S729C mutation within the S1S2 region of the GluR2 DATD receptor raised the possibility that we could make the mutation in the context of the readily crystallized GluR2 S1S2 ligand-binding core and determine the structure of the disulfide-linked dimer by X-ray crystallography. Crystals of the GluR2 S1S2 S729C dimer formed readily in the presence of glutamate and diffracted to 2.3 Å . The structure was determined by molecular replacement using the S1S2-glutamate protomer as a search probe. Difference Fourier maps (>4s) revealed unambiguous density for a disulfide bridge between the cysteine residues at position 729 ( Figure 6A ).
The S1S2 S729C crystal structure contains two protomers in the asymmetric unit, arranged around an approximate 2-fold axis of molecular symmetry ( Figure 6A ). Superimposing the S1S2 S729C dimer on the S1S2 L483Y dimer, which is a model for the nondesensitized state, revealed a dramatic change in the relative orientation of protomers ( Figures 6B and 6C ). In the L483Y dimer, the dimer interface is anchored by residues from domain 1, allowing domain 2 to move upon agonist binding. In the ''relaxed'' S729C dimer, all interactions that stabilize the L483Y dimer interface are disrupted. For example, the a carbons of Gly739, Gly743, and Lys493 are located 13.5, 12.1, and 9.2 Å farther apart, respectively, than in the L483Y dimer ( Figure 6D ). The separation of residues in the domain 1 interface is concomitant with an increased proximity of sites within domain 2. The pseudo 2-fold related 729 a carbon atoms were separated by 13 Å in the L483Y structure and are now 6.6 Å apart in S729C. Most importantly, residues in the S1S2 ''linker,'' which replaces the ion channel membrane domains, move closer by $10 Å relative to their positions in the L483Y-AMPA crystal structure, suggesting a mechanism for ion channel closure upon receptor desensitization ( Figure 6D ).
Unlike the L483Y dimer, the S1S2 S729C dimer deviates by $12 from 2-fold symmetry, resulting in a single interface created by interactions between residues in the loop between helices F and G in one subunit (A) and helix K of the adjacent protomer (B) ( Figure 6E ). Although dimer formation buries $480 Å 2 of solvent accessible surface area on each subunit, the interface is composed of only three hydrogen bonds and a salt bridge, in addition to the disulfide bond. Two hydrogen bonds are formed between Asn764 (A) and the backbone carbonyl and amide atoms of residues Lys663 (B) and Ala665 (B), respectively. The third hydrogen bond is between Asp760 (A) and the backbone amide of Lys663 (B). The salt link occurs between Arg661 (B) and Glu755 (A). Compared to the interface observed in the L483Y structures, the S729C interface contains relatively few interactions and buries $600 Å 2 less surface area.
Accompanying the large change in protomer orientation is a small change in the conformation of individual protomers. Superposition of S729C protomers with the wildtype glutamate bound structure yields root mean squared deviation (rmsd) values of 0.6 and 0.7 Å for protomers A and B, respectively. The rmsd values are elevated because the lobes of the S729C protomers are $4 more closed than in the wild-type structure. Several additional electrostatic interactions across the binding cleft stabilize this new conformation. The backbone amide of Gly451 forms a hydrogen bond with the side chain hydroxyl of Ser652, and the side chain of Lys449 interacts with both Ser652 and Arg684.
To test the specificity of the relaxed dimer configuration, we determined the crystal structure of the GluR2 S1S2 G725C dimer, also bound to glutamate. The S1S2 G725C asymmetric unit contains two relaxed dimers, both with clear electron density for the disulfide bond between G725C residues on adjacent protomers. The S729C and G725C S1S2 dimers are similar in structure with rmsd values of $1.5 Å for superposition of all Ca atoms. Nevertheless, the domain 1-domain 1 interface is more separated in the G725C structures, presumably because the location of the tethering disulfide bond is simply different from that of S729C ( Figure 6F ).
DISCUSSION
It is an unfortunate paradox that the most energetically stable state of glutamate receptors, the desensitized conformation, has also proven the most resistant to structural investigation. There are now well over 50 crystal structures of glutamate receptor ligand-binding cores, including several from each of the three receptor subtypes as well as a bacterial homolog (Mayer, 2005; Mayer and Armstrong, 2004) . In most of these structures the protomers associate in a similar manner, forming a 2-fold symmetric dimer that is held together by interactions formed mainly between residues in domain 1. However, there is little knowledge of the structure of the desensitized state.
S729C Is Locked in a Desensitized State
How do we know that S729C traps a desensitized conformation of the receptor? The extremely small currents elicited from unreduced S729C oocytes and the $56-fold potentiation following reduction suggested that the disulfide bond constrains the receptor to a closed-channel conformation, but they do not tell us whether the state is similar to a resting or a desensitized state. However, these states can be distinguished on the basis of their agonistbinding affinities; the calculated glutamate affinity for the desensitized state is $4000-fold higher affinity than the resting state (Robert et al., 2005) . We find that unreduced S729C binds 3 H-AMPA with an affinity similar to wild-type and that binding counts do not increase following treatment with reducing agent. Furthermore, in the G725H mutant, quisqualate potency is unchanged by the presence of 100 mM zinc even though this concentration of ions inhibits receptor currents by $50%. These results indicate that tethering together sites within domain 2 does not compromise the ability of the receptor to bind agonists, thereby demonstrating that S729C is not locked in a resting state.
Support for the notion that S729C traps a desensitized state comes from the L483Y/S729C double mutant. Introduction of the L483Y mutation (Stern-Bach et al., 1998) into the S729C background reduces the propensity (A) Maximal glutamate-induced currents from S729C and L483Y/ S729C oocytes and from S729C oocytes in 100 mM CTZ. Oocytes were injected with 2.5 ng of each construct and currents were measured 3 days post-injection. Mean I max values are 0.02 ± 0.01 mA (n = 20), 1.30 ± 0.57 mA (n = 7), and 0.20 ± 0.05 mA (n = 3) for S729C, L483Y/S729C, and S729C + CTZ, respectively. (B) Mean fold potentiation following 5 min exposure to 2 mM DTT is decreased for L483Y/S729C relative to S729C. The mean fold potentiation is 55.5 ± 12.8 (n = 9) and 20.7 ± 3.6 (n = 5) for S729C and L483Y/S729C, respectively. All errors are SEM.
for spontaneous disulfide formation as judged by SDS-PAGE and decreases the extent of DTT-induced current potentiation. Strictly speaking, the fact that a mutation that preferentially stabilizes the nondesensitized state inhibits spontaneous disulfide bond formation only suggests that the disulfide bonded state is different from the nondesensitized state. If the S729C, G725C, and G725H mutations stabilize a desensitized state, then one would predict that the presence of Zn 2+ would slow the rate at which the GluR2 DATD G725H mutant recovers from desensitization. A slowing of recovery from desensitization in the presence of zinc would indicate that, upon desensitization, domain 2 of each subunit in a dimer comes close enough together to form a histidine-zinc bridge.
S729C and G725C Structures Depict a Desensitized S1S2 Dimer How do we know that the crystal structures are representative of the native desensitized conformation? Perhaps the strongest evidence that the S729C and G725C structures define a conformation representative of the desensitized state comes from the agreement between the distances obtained from the crosslinking data and those measured in the crystal structures. To gauge these similarities we modeled cysteines into the S729C and G725C crystal structures at positions 493, 739, and 743 using side chain rotomer conformations that minimized the distance separating the cysteines across the dimer interface. Plotting the mean of these distances versus the length of the longest potentiating crosslinkers for the three tested positions shows a striking correlation between the crosslinking data and the crystal structures ( Figure 7A ). The resemblance between the native desensitized state and the S729C and G725C crystal structures is also supported by several reports in the literature. First, kinetic studies conclude that in the desensitized state the binding cleft conformations of the two subunits in an AMPA receptor dimer differ, with one subunit being stabilized in a closed-cleft conformation exhibiting a slower rate of glutamate dissociation (Robert and Howe, 2003) . Indeed, we find that the S729C and G725C dimers deviate significantly from perfect 2-fold symmetry, and this deviation from 2-fold symmetry might give rise to differences in the rate of glutamate dissociation. Second, it has recently been shown that the ATD orientation in AMPA receptors changes substantially upon desensitization (Nakagawa et al., 2005) . Movement of the ATDs is simply the consequence of the rigid body separation of domain 1 on each subunit. Third, a mutational analysis of the entire length of helix J concluded that no sites in this region contribute to stabilization of the desensitized conformation (Horning and Mayer, 2004) . Residues in helix J, which participate in many crucial interactions in the nondesensitized state, make no interprotomer contacts in the S1S2 S729C and G725C crystal structures.
Although the overall trends between the functional and structural data are consistent, we are not under the illusion Table S1 ). (B) Shown are two subunits of the tetramer, with the ATD omitted and the transmembrane domains represented by a single green cylinder. Glutamate binds to the receptor and domain closure occurs, with two possible outcomes: either the D1-D1 interface remains fixed and the domain closure is translated into ion activation, or the D1-D1 interface ruptures and the ion channel closes, leading to the desensitized state. All errors are SEM.
that the S729C and G725C crystal structures are replicas of the native desensitized state. Indeed, there are modest inconsistencies in our data that suggest that the native desensitized conformation differs in subtle ways from our structures. For instance, the longest crosslinker is 25.1 Å yet it potentiates G739C currents even though the mean distance between modeled cysteine sulfhydryls in the S729C and G725C crystal structures is $23.0 Å . Likewise, K493C currents are potentiated by the 12.5 Å crosslinker, but the mean sulfhydryl separation is 11.6 Å . On the whole, these differences are smaller than the overall conformational change occurring upon desensitization and likely within the uncertainty of our measurements. At present we do not understand why currents recorded from the I664C mutant are potentiated $3-fold following DTT reduction. In the S1S2 S729C and G725C crystal structures the a carbons of residue 664 are separated by $32 Å . Perhaps I664 is located at a dimer-dimer interface and the I664C mutant forms inter-rather than intradimer crosslinks.
Mechanism of Desensitization
GluR2 desensitizes rapidly (t $4.2-7.9 ms) and profoundly (98.5%) in the continued presence of glutamate (Horning and Mayer, 2004; Robert et al., 2005) . The large preference for the desensitized conformation at steady state indicates the presence of a highly stable receptor conformation. However, the interface observed in the S729C and G725C dimers is relatively small, containing just a few hydrogen bonds and one salt bridge. This observation, combined with the fact that desensitized-like conformations of GluR2 S1S2 do not predominate in either solution or the crystal lattice, suggest that the interface seen in the G725C and S729C dimers makes a minor contribution to the overall stability of the desensitized state. We further suggest that the S1S2 portion of the receptor does not participate in any significantly stabilizing interprotomer interactions in the desensitized conformation. Instead we propose that the stability of the desensitized state is determined by interactions holding the S1S2-binding core in a closed-cleft conformation, together with interactions between juxta-membrane and transmembrane domains (Ren et al., 2003; Yelshansky et al., 2004) . Indeed, the relationship between agonist potency and occupancy of the desensitized state was recently demonstrated with a series of GluR2 mutants at position 686, a site which makes an important interdomain hydrogen bond in the wild-type GluR2 structures (Robert et al., 2005) . Robert et al. (2005) found that decreased glutamate potency correlates with both an increase in steady-state current and with faster rates of recovery from desensitization. This indicates that the ability of the ligand-binding core to remain tightly closed is an important determinant of desensitized state stability, a conclusion in harmony with crystallographic and electrophysiological studies on GluR2 and 5-substituted willardiine derivatives (Jin et al., 2003) .
The driving force for desensitization and subsequent channel closure necessarily originates in the ligand-binding domain. Upon binding of glutamate, the clamshell closes and one of two routes is taken ( Figure 7B ). Either the dimer interface remains intact and the ion channel opens, or the dimer interface disengages and the receptor enters the desensitized state. Receptors that enter the open-channel state do so only briefly as the closed-binding domain/open-channel conformation is high energy. After channel opening, the dimer interface of these receptors also disengages and they, too, enter the desensitized state. We propose that dimer disengagement involves a $6-13 Å separation of the domain 1-domain 1 interface, with regions at the ''top'' of the dimer separating the most and regions near the ''middle'' of the dimer separating the least. As a consequence of this movement, regions in domain 2, particularly the beginning of the second interdomain b strand, are brought close together. The cysteine residues we engineered into this b strand (G725C, S729C) spontaneously form a disulfide bond, locking the receptor in the desensitized state. The crystal structures of these mutants show that dimer rearrangement brings the linker regions, which replace the ion channel domain in the S1S2 construct, $10 Å closer together relative to their positions in the L483Y crystal structure, demonstrating that dimer rearrangement neutralizes binding-domain closure by allowing the linker regions to rotate back into close proximity, thereby closing the ion channel gate.
EXPERIMENTAL PROCEDURES
Molecular Biology
The rat GluR2-flip gene (Gly at R/G editing site) was used for the electrophysiology experiments. In the DATD construct, the S1 segment of the mature protein begins at Ser382. This construct contains the wildtype GluR2 signal sequence linked to S1 by a three residue linker (AlaMet-Gly). All point mutations were incorporated by PCR, followed by DNA sequencing of the entire gene. For the C-terminal GFP fusion constructs, the DATD and S729C genes were amplified and cloned into pcDNA5 (Invitrogen).
Electrophysiology
Xenopus oocyte preparation, injection, and recordings were carried out as previously described (Armstrong et al., 2003) . Methanethiosulfonate reagents (Toronto Research Chemicals) were prepared in either water (MTSES) or DMSO (crosslinkers). Stocks were aliquoted, frozen immediately in liquid nitrogen, stored at À80 C, and used within 10 min after thawing. Data were acquired using Pulse (Heka) and processed in Igor (Wavemetrics) and Kaleidograph. Data are presented as mean ± SEM.
H AMPA Binding
HEK293 cells were stably transfected with C-terminal GFP fusions of the DATD and S729C constructs. Cells were grown in 15 cm dishes, induced with tetracycline at 70%-80% confluency, and harvested 24-48 hr post-induction. The cell pellet was resuspended in 400 ml PBS with protease inhibitors using a glass homogenizer. Membranes were pelleted by centrifugation at 40,000 rpm for 15 min at 4 C. This washing process was repeated twice, with the final resuspension carried out in AMPA binding buffer (ABB-30 mM Tris, pH 7.4, 100 mM KSCN, 2.5 mM CaCl 2 ). For comparative quantification of control and mutant protein expression levels, a 10 ml aliquot of membranes was solubilized in 100 ml of 20 mM dodecylmaltoside for 2 hr at 4 C. The solution was cleared by centrifugation, and fluorescence of the supernatant at 490-530 nm was measured in a Fluoromax-3 (Horiba) by GFP excitation at 480 nm. 3 H-AMPA binding measurements were performed essentially as described previously (Armstrong and Gouaux, 2000) .
Western Blotting
Three to five healthy oocytes per construct were tested for current and selected for SDS-PAGE. Oocytes were lysed by pipetting in 30 ml/oocyte of 20 mM Tris, pH 7.4, 100 mM NaCl, and 1% Triton X-100 plus protease inhibitor cocktail (Sigma); samples were run on 10% acrylamide gels analyzed by western blotting using an anti-GluR2/3 primary antibody (Chemicon). Bands were visualized by chemiluminescence.
S1S2 Crystallization
The S729C and G725C mutations were incorporated into the S1S2J construct (Armstrong and Gouaux, 2000) by PCR and the resulting proteins were expressed and purified using methods described before (Furukawa and Gouaux, 2003) . Disulfide-bond formation was catalyzed by 500-700 mM CuSO 4 and 1.0-1.4 mM 1,10-phenanthroline. Samples were incubated at 4 C for 30 min and reactions were terminated by addition of 3 mM EDTA. The quenched reaction mixture was digested with trypsin and the desired dimer was isolated by ion exchange and size-exclusion chromatography. The molecular mass of the dimer was confirmed using SDS-PAGE and MALDI-TOF. The proteins were dialyzed against 10 mM HEPES (pH 7.0), 20 mM NaCl, 1 mM EDTA, and 10 mM glutamate and concentrated to 10 mg/ml. Crystals were grown by vapor diffusion at 4 C with 1:1, 1:2, and 2:1 ratio (v/v) of protein to reservoir solution (0.1 M cacodylate [pH 6.5], 18% PEG 8K, and 20 mM zinc acetate). Prior to cryo-cooling with liquid nitrogen, crystals were soaked in reservoir buffer supplemented with 20% glycerol and 10 mM glutamate.
Structure Determination and Refinement
Data sets were collected at NSLS (X4A) and indexed, integrated, and scaled with HKL2000 (see Tables S2 and S3 ). The S729C and G725C structures were solved by molecular replacement (Navaza, 1994 ) using a single glutamate bound protomer (Protein Data Bank ID code 1FTJ) as a search probe. Molecular replacement phases were improved by density modification using DM (CCP4, 1994). Iterative cycles of manual building, solvent addition, and crystallographic refinement were carried out with O (Jones et al., 1991) and CNS (Brunger et al., 1998) until the R/R free values converged.
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